Global Antihypertensive Drugs Market 2019-2023| Evolving Opportunities with AstraZeneca and Johnson & Johnson Services, Inc. | Technavio
LONDON--(BUSINESS WIRE)--Nov 19, 2019--
Technavio has been monitoring the global antihypertensive drugs market and the market is poised to grow by USD 3.96 billion during 2019-2023 at a CAGR of over 2% during the forecast period. Request Free Sample Pages
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191119005467/en/
Technavio has announced its latest market research report titled global antihypertensive drugs market 2019-2023 (Graphic: Business Wire)
Read the 124-page research report with TOC on “Antihypertensive Drugs Market Analysis Report by Type (Systemic hypertension and Pulmonary hypertension), by Geography (Asia, Europe, North America, and ROW), and Segment Forecasts, 2019 - 2023”.
The market is driven by the availability of a wide range of antihypertensive drugs. In addition, the development of modified-release formulations is anticipated to further boost the growth of the antihypertensive drugs market.
Physicians prescribe antihypertensive drugs for patients suffering from hypertension. These drugs are developed to minimize cardiac output by depressing stroke volume and heart rate. Some antihypertensive drugs reduce systemic vascular resistance or central venous pressure and cardiac output. Indapamide and polythiazide are some of the examples of these drugs. Thus, the availability of a wide range of drugs is expected to drive market growth during the forecast period.
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
Major Five Antihypertensive Drugs Market Companies:
AstraZeneca is headquartered in the UK and operates under the business segment: Biopharmaceuticals. The company offers DUTOPROL, which is a metoprolol succinate extended-release or a hydrochlorothiazide.
Johnson & Johnson Services, Inc.
Johnson & Johnson Services, Inc. is headquartered in the US and offers products through the following business units: Consumer, Pharmaceutical, and Medical devices. The company offers OPSUMIT, TRACLEER, UPTRAVI, VELETRI, and VENTAVIS.
Merck & Co., Inc.
Merck & Co., Inc. is headquartered in the US operates under various business segments, namely Pharmaceutical and Other. The company offers COZAAR, HYZAAR, and PRINIVIL. In addition, the company caters to end-users such as hospitals and pharmacies.
Novartis AG is headquartered in Switzerland and offers products through the following business segments: Innovative medicines, Sandoz, and Alcon. The company offers DIOVAN, DIOVAN HCT, ENTRESTO, EXFORGE HCT, and LOTREL.
Pfizer Inc. is headquartered in the US and offers products through the following business segments: Innovative health and Essential health. The company offers ACCURETIC, NORVASC, and REVATIO. They cater to end-users such as hospitals and pharmacies.
Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio’s SUBSCRIPTION platform
Antihypertensive Drugs Type Outlook (Revenue, USD Million, 2019 - 2023)
- Systemic hypertension
- Pulmonary hypertension
Antihypertensive Drugs Regional Outlook (Revenue, USD Million, 2019 - 2023)
- North America
Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more.Request a free sample report
Related Reports on Health Careare:
Pericarditis Drugs Market – Global Pericarditis Drugs Market by product (NSAIDs, colchicine, and others) and geography (Asia, Europe, North America, and ROW).
Pruritus Drugs Market – Global Pruritus Drugs Market by application (hematologic pruritus, oncological pruritus, renal pruritus, endocrine pruritus, and cholestatic pruritus), RoA (topical, oral, and parenteral) and geography (Asia, Europe, North America, and ROW).
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
View source version on businesswire.com:https://www.businesswire.com/news/home/20191119005467/en/
Technavio ResearchJesse MaidaMedia & Marketing ExecutiveUS: +1 844 364 1100UK: +44 203 893 3200Email:firstname.lastname@example.org Website:https://www.technavio.com
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Technavio Research
Copyright Business Wire 2019.
PUB: 11/19/2019 08:30 AM/DISC: 11/19/2019 08:30 AM